Antibodies.com is a digital marketplace that enables life scientists to purchase cost-effective & validated antibodies, proteins, and immunoassays directly from the primary manufacturers.
Missing: Antibodies.com's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Antibodies.com's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest Antibodies.com News
Jul 2, 2019
FinSMEs Search for: Antibodies.com , a Cambridge, UK-based digital marketplace that enables life scientists to purchase critical research reagents from primary manufacturers, raised £400k in pre-seed financing. Nidobirds Ventures joined local angel investors and industry veterans in the funding round. The company intends to use the funds to expand its catalogue of off-the-shelf reagents, implement new sales and marketing programs to drive customer acquisition, and scale its proprietary AI assisted “Product Matching” tool. Led by Sebastian Newlove, Antibodies.com is a digital marketplace that enables life scientists to purchase validated antibodies, proteins, and immunoassays directly from the primary manufacturers. The company launched out of beta in May 2018 and has since grown to work with 50+ supply chain partners, offers 70,000+ research reagents, and operates across North America and Europe. Customers now include some of the world’s largest pharmaceutical companies (including Glaxo Smith Kline, Glenmark Pharmaceuticals, and Merck & Co) and leading academic research institutions (including MIT, Standard University, University of Cambridge, and University of Oxford). FinSMEs
Antibodies.com Frequently Asked Questions (FAQ)
When was Antibodies.com founded?
Antibodies.com was founded in 2015.
Where is Antibodies.com's headquarters?
Antibodies.com's headquarters is located at 8 Station Court, Station Road, Cambridge.
What is Antibodies.com's latest funding round?
Antibodies.com's latest funding round is Pre-Seed.
How much did Antibodies.com raise?
Antibodies.com raised a total of $500K.
Who are the investors of Antibodies.com?
Investors of Antibodies.com include Nidobirds Ventures.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.